Cargando…

Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF

Background: Around 20–25 percent of the world’s adult populations have the metabolic syndrome and they are twice as likely to die from heart attack or stroke compared with people without the syndrome. The World Health Organization proposed a definition for the metabolic syndrome in 1998 and later on...

Descripción completa

Detalles Bibliográficos
Autores principales: Lone, Shafat, Lone, Kouser, Khan, Saika, Pampori, Rafiq Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384570/
https://www.ncbi.nlm.nih.gov/pubmed/29110863
http://dx.doi.org/10.1016/j.jegh.2017.07.004
_version_ 1783563629433454592
author Lone, Shafat
Lone, Kouser
Khan, Saika
Pampori, Rafiq Ahmed
author_facet Lone, Shafat
Lone, Kouser
Khan, Saika
Pampori, Rafiq Ahmed
author_sort Lone, Shafat
collection PubMed
description Background: Around 20–25 percent of the world’s adult populations have the metabolic syndrome and they are twice as likely to die from heart attack or stroke compared with people without the syndrome. The World Health Organization proposed a definition for the metabolic syndrome in 1998 and later on NCEP ATPIII and IDF provided new definitions of this syndrome in 2001 and 2003 respectively. Very few studies have compared the different definitions to diagnose the metabolic syndrome in type two diabetics in India while as for Kashmir valley no such documented study has been carried out till date. Objective: To study the prevalence of metabolic syndrome in type 2 Kashmir diabetics and to find out the degree of agreement between three different criteria given by WHO, NCEPATPIII and IDF for diagnosis of metabolic syndrome. Materials and Method: A cross sectional study was conducted in one of the two tertiary care hospitals of Kashmir, India. About 1000 patients were selected and their demographic, clinical and biochemical parameters were studied after obtaining informed consent from each patient. Results: Prevalance of metabolic syndrome was found to be highest(84.5%) while using WHO definition.Kappa statistic between WHO, ATP III and WHO, IDF definitions was 0.697 (95% CI 0.637–0.754) and 0.775 (95%CI 0.72–0.82) respectively while the degree of agreement between IDF and ATP III definitions was highest with kappa of 0.851 (95%CI 0.810–0.889). Conclusion: Our study warrants for interventions to prevent the progression towards this syndrome among type 2 diabetics as early as the diagnosis of diabetes is made.
format Online
Article
Text
id pubmed-7384570
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Atlantis Press
record_format MEDLINE/PubMed
spelling pubmed-73845702020-07-28 Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF Lone, Shafat Lone, Kouser Khan, Saika Pampori, Rafiq Ahmed J Epidemiol Glob Health Article Background: Around 20–25 percent of the world’s adult populations have the metabolic syndrome and they are twice as likely to die from heart attack or stroke compared with people without the syndrome. The World Health Organization proposed a definition for the metabolic syndrome in 1998 and later on NCEP ATPIII and IDF provided new definitions of this syndrome in 2001 and 2003 respectively. Very few studies have compared the different definitions to diagnose the metabolic syndrome in type two diabetics in India while as for Kashmir valley no such documented study has been carried out till date. Objective: To study the prevalence of metabolic syndrome in type 2 Kashmir diabetics and to find out the degree of agreement between three different criteria given by WHO, NCEPATPIII and IDF for diagnosis of metabolic syndrome. Materials and Method: A cross sectional study was conducted in one of the two tertiary care hospitals of Kashmir, India. About 1000 patients were selected and their demographic, clinical and biochemical parameters were studied after obtaining informed consent from each patient. Results: Prevalance of metabolic syndrome was found to be highest(84.5%) while using WHO definition.Kappa statistic between WHO, ATP III and WHO, IDF definitions was 0.697 (95% CI 0.637–0.754) and 0.775 (95%CI 0.72–0.82) respectively while the degree of agreement between IDF and ATP III definitions was highest with kappa of 0.851 (95%CI 0.810–0.889). Conclusion: Our study warrants for interventions to prevent the progression towards this syndrome among type 2 diabetics as early as the diagnosis of diabetes is made. Atlantis Press 2017 2017-08-09 /pmc/articles/PMC7384570/ /pubmed/29110863 http://dx.doi.org/10.1016/j.jegh.2017.07.004 Text en © 2017 Ministry of Health, Saudi Arabia. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Lone, Shafat
Lone, Kouser
Khan, Saika
Pampori, Rafiq Ahmed
Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF
title Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF
title_full Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF
title_fullStr Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF
title_full_unstemmed Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF
title_short Assessment of metabolic syndrome in Kashmiri population with type 2 diabetes employing the standard criteria’s given by WHO, NCEPATP III and IDF
title_sort assessment of metabolic syndrome in kashmiri population with type 2 diabetes employing the standard criteria’s given by who, ncepatp iii and idf
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384570/
https://www.ncbi.nlm.nih.gov/pubmed/29110863
http://dx.doi.org/10.1016/j.jegh.2017.07.004
work_keys_str_mv AT loneshafat assessmentofmetabolicsyndromeinkashmiripopulationwithtype2diabetesemployingthestandardcriteriasgivenbywhoncepatpiiiandidf
AT lonekouser assessmentofmetabolicsyndromeinkashmiripopulationwithtype2diabetesemployingthestandardcriteriasgivenbywhoncepatpiiiandidf
AT khansaika assessmentofmetabolicsyndromeinkashmiripopulationwithtype2diabetesemployingthestandardcriteriasgivenbywhoncepatpiiiandidf
AT pamporirafiqahmed assessmentofmetabolicsyndromeinkashmiripopulationwithtype2diabetesemployingthestandardcriteriasgivenbywhoncepatpiiiandidf